Wegovy users keep weight off for four years, Novo Nordisk study says – Reuters

1. Wegovy users keep weight off for four years, Novo Nordisk study says  Reuters
2. What the results of Wegovy’s longest clinical trial yet show about weight loss, side effects and heart protection  CNN
3. People on Novo Nordisk’s Wegovy maintain weight loss for up to four years, study says  CNBC
4. Weight loss drug could reduce heart attack risk by 20%, study finds  The Guardian
5. Ozempic Drug Semaglutide Could Cut Heart Risk By 20%—Regardless Of Weight Loss, Study Finds  Forbes